MétaCan
Menu
Back to cohort

A Performance Comparison of Three Nebulizers Delivering a Combination of Ipratropium/Albuterol Inhalation Solution

2025· article· en· W4410272631 on OpenAlexaff
JUDY SCHLOSS, Jason Suggett, M. Nagel, D.P. Coppolo

Bibliographic record

VenueAmerican Journal of Respiratory and Critical Care Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicInhalation and Respiratory Drug Delivery
Canadian institutionsTrudell Medical International (Canada)
Fundersnot available
KeywordsMedicineInhalationIpratropiumIpratropium bromideNebulizerAnesthesiaBronchodilatorBronchodilator AgentsIntensive care medicineAsthmaInternal medicine

Abstract

fetched live from OpenAlex

Abstract Rationale: More than one medication may be combined in a nebulizer to treat pulmonary symptoms. This can add to the time spent delivering therapy and lack clarity on medication dosing. High efficiency nebulizers are designed to increase medication delivery to the distal airways while maintaining aerosol particle sizes within the respirable range <5 μm. This study aimed to compare three nebulizers by assessing in-vitro Fine Droplet Mass (FDM<4.7μm) and aerosol characteristics of a combination of ipratropium/albuterol over time.Methods: AeroEclipse® II BAN® Nebulizer (AE), AirLife™ Misty Fast™ (MF) and Circulaire® II (CA) devices (n=5) were filled with 1 DuoNeb® (ipratropium bromide 0.5 mg/ albuterol sulfate 3.0 mg) vial. Each nebulizer was connected to a breathing simulator (ASL5000) simulating adult tidal breathing (tidal volume=500 mL; rate=10-cycles/min; duty cycle=33%). A filter was positioned between the test lung and the nebulizer to capture inspired aerosol. The filter was changed every minute and output was determined using HPLC. Parallel measurements for Fine Droplet Fraction <4.7 μm diameter (FDF<4.7μm) were made with each nebulizer using a laser diffractometer (Spraytec). FDM<4.7μm was determined as the product of mass recovered from the filters and FDF<4.7μm.Results: FDM<4.7μm with elapsed time is given in the Figure below.Mean FDF<4.7μm was 84.5%, 52.6% and 62.8% for the AE, MF and CA respectively. At each time point, FDM<4.7μm from the AE significantly exceeded that from either of the small volume nebulizers (SVN). The addition of the breath actuation feature of the AeroEclipse® BAN® Nebulizer allowed for similar FDM delivery in half the amount of time compared to either the AirLife™ Misty Fast™ or the Circulaire® II SVNs.Conclusion: All nebulizers showed consistent incremental increases in delivered doses of each medication minute by minute. The AeroEclipse® BAN® Nebulizer provided the highest FDM in substantially less time compared to the other nebulizers tested making this a reasonable option for recognizing a time savings by offering a timed treatment option. The effectiveness of small volume nebulizers can vary greatly, making it crucial to choose the right one to optimize drug delivery and achieve the best therapeutic outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.327
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of Respiratory and Critical Care MedicineSame topicInhalation and Respiratory Drug DeliveryFrench-language works237,207